Press-release for stocks for biogen inc. for AZNCF

| Email alert Add to watchlist
VTRS | $11.195 -1.1% 470K

| Email alert Add to watchlist
NVSEF | $93.6375 82K

| Email alert Add to watchlist
AZN | $68.34 -0.57% 750K

| Email alert Add to watchlist
GLAXF | $20.2 510

| Email alert Add to watchlist
GSK | $39.9 -1.48% 650K

| Email alert Add to watchlist
AZNCF | $135.94 770

| Email alert Add to watchlist
JAZZ | $110.57 -0.31% 72K

| Email alert Add to watchlist
NVS | $93.07 -1.42% 280K

| Email alert Add to watchlist
AMGN | $265.07 -0.17% 280K

| Email alert Add to watchlist
cancer cell global growth market

Protein Inhibitors Global Market Report 2024 - A $125 Billion Market in 2028, Registering Compound Annual Growth of 9%
Published: 2024-02-14 (Crawled : 02:00) - prnewswire.com
LZAGF | $577.676 25

| 15.54% | O: 3.14% H: 1.92% C: 1.92%
GLAXF | $20.2 510

| -3.81% | O: -2.14% H: 0.0% C: -0.63%
SNYNF | $92.966 630

| -0.01% | O: -2.71% H: 0.0% C: 0.0%
AZNCF | $135.94 770

Professional, Scientific, and T...

| 10.07% | O: 0.87% H: 0.21% C: -2.23%
LZAGY | $58.05 27K

| 16.92% | O: 4.07% H: 1.53% C: 1.45%
TMO | $554.06 -0.68% 110K

| 3.58% | O: 0.56% H: 1.3% C: 1.22%
TAK | $13.275 0.72% 150K

| -8.09% | O: 0.42% H: 1.04% C: 0.97%
JNJ | $144.84 -1.86% 3M

| -6.41% | O: -0.91% H: 0.0% C: 0.0%
GSK | $39.9 -1.48% 650K

| -2.15% | O: 0.89% H: 0.41% C: 0.1%
LLY | $749.58 -0.16% 450K

| 1.05% | O: 0.38% H: 2.44% C: 1.54%
BAX | $39.685 -0.89% 380K

| 1.06% | O: 0.33% H: 0.63% C: -0.28%
ABBV | $163.08 0.87% 500K

| -7.33% | O: -0.73% H: 0.0% C: 0.0%
ABT | $108.85 -0.04% 860K

| -3.27% | O: -0.83% H: 0.66% C: 0.38%
SNY | $45.99 0.13% 70K

| 1.52% | O: -1.1% H: 0.0% C: 0.0%
GLPG | $29.51 -0.97% 63K

| -23.71% | O: -1.72% H: 1.8% C: 1.59%
BIIB | $195.95 -0.43% 70K

| -13.17% | O: 0.16% H: 0.43% C: -2.76%
AZN | $68.34 -0.57% 750K

| 12.62% | O: 0.28% H: 0.93% C: 0.75%
AMGN | $265.07 -0.17% 280K

| -8.6% | O: -0.21% H: 0.34% C: 0.07%
report global protein growth market

Listeria Monocytogenes Infections Treatment Global Market Report 2024: Global Expansion in Listeria Monocytogenes Treatment Sector Predicted Amid Rising Foodborne Disease Incidence
Published: 2024-02-14 (Crawled : 00:00) - prnewswire.com
GLAXF | $20.2 510

| -3.81% | O: -2.14% H: 0.0% C: -0.63%
SNYNF | $92.966 630

| -0.01% | O: -2.71% H: 0.0% C: 0.0%
AZNCF | $135.94 770

| 10.07% | O: 0.87% H: 0.21% C: -2.23%
GSK | $39.9 -1.48% 650K

| -2.15% | O: 0.89% H: 0.41% C: 0.1%
LLY | $749.58 -0.16% 450K

| 1.05% | O: 0.38% H: 2.44% C: 1.54%
VRTX | $396.12 -0.31% 60K

| -4.49% | O: 0.56% H: 0.49% C: -0.12%
SNY | $45.99 0.13% 70K

| 1.52% | O: -1.1% H: 0.0% C: 0.0%
BIIB | $195.95 -0.43% 70K

| -13.17% | O: 0.16% H: 0.43% C: -2.76%
AZN | $68.34 -0.57% 750K

| 12.62% | O: 0.28% H: 0.93% C: 0.75%
AMGN | $265.07 -0.17% 280K

| -8.6% | O: -0.21% H: 0.34% C: 0.07%
disease report treatment expansion global infections market

Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published: 2024-02-12 (Crawled : 23:00) - prnewswire.com
GLAXF | $20.2 510

| -1.6% | O: 3.52% H: 0.0% C: -1.18%
AZNCF | $135.94 770

| 12.66% | O: 0.06% H: 2.34% C: 2.29%
ALPMY | $9.2715 500K

| -14.31% | O: 0.37% H: 0.74% C: 0.28%
TAK | $13.275 0.72% 150K

| -7.9% | O: 0.14% H: 0.35% C: 0.07%
NVS | $93.07 -1.42% 280K

| -6.09% | O: -0.34% H: 0.23% C: -1.13%
JNJ | $144.84 -1.86% 3M

| -5.76% | O: 0.7% H: 0.0% C: 0.0%
GSK | $39.9 -1.48% 650K

| -1.39% | O: 1.22% H: 0.07% C: -0.43%
LLY | $749.58 -0.16% 450K

| 1.83% | O: -0.96% H: 1.75% C: 1.75%
BMY | $48.325 -0.38% 1M

| -2.49% | O: -0.18% H: 0.48% C: -1.91%
ABBV | $163.08 0.87% 500K

| -6.59% | O: 0.8% H: 0.0% C: 0.0%
ZLAB | $14.065 -0.95% 37K

| -22.02% | O: -1.15% H: 1.03% C: -1.5%
VRTX | $396.12 -0.31% 60K

| -5.06% | O: -0.28% H: 0.49% C: -0.32%
SNY | $45.99 0.13% 70K

| 1.45% | O: -0.06% H: 0.0% C: 0.0%
IPHA | $2.42 4.5K

| -6.2% | O: -3.1% H: 1.2% C: -0.8%
INCY | $53.85 0.79% 100K

| -7.62% | O: 3.8% H: 1.1% C: -1.17%
BIIB | $195.95 -0.43% 70K

| -19.59% | O: -3.72% H: 0.58% C: -3.82%
AZN | $68.34 -0.57% 750K

| 11.92% | O: -0.26% H: 0.73% C: -0.36%
ARGX | $369.92 -1.69% 61K

| -3.4% | O: -2.3% H: 1.65% C: 0.83%
AMGN | $265.07 -0.17% 280K

| -9.82% | O: 0.06% H: 0.31% C: -1.4%
expansion growth market

Biologics Global Market Forecast Report 2024-2034 - Challenges Posed by Patent Expiration for Biologics
Published: 2023-12-22 (Crawled : 17:00) - prnewswire.com
SNYNF | $92.966 630

| -2.97% | O: 3.66% H: 0.0% C: -0.12%
AZNCF | $135.94 770

| 4.17% | O: 3.33% H: 0.0% C: -2.93%
NVO | $123.5 -0.32% 1M

| 19.73% | O: -0.31% H: 0.39% C: -0.44%
JNJ | $144.84 -1.86% 3M

| -3.86% | O: 1.09% H: 0.0% C: 0.0%
LLY | $749.58 -0.16% 450K

| 31.25% | O: 0.18% H: 0.5% C: -0.46%
BMY | $48.325 -0.38% 1M

| -5.36% | O: -0.78% H: 5.15% C: 2.81%
ABBV | $163.08 0.87% 500K

| 5.95% | O: 0.58% H: 0.0% C: 0.0%
SNY | $45.99 0.13% 70K

| -3.82% | O: 1.03% H: 0.0% C: 0.0%
REGN | $895.11 -0.38% 53K

| 6.73% | O: 0.52% H: 0.58% C: 0.05%
GILD | $67.36 -0.58% 700K

| -14.16% | O: 0.34% H: 1.02% C: 0.59%
BIIB | $195.95 -0.43% 70K

| -22.48% | O: 0.57% H: 1.36% C: 1.04%
AZN | $68.34 -0.57% 750K

| 3.67% | O: 1.06% H: 0.18% C: -1.06%
AMGN | $265.07 -0.17% 280K

| -4.95% | O: 0.24% H: 2.03% C: 1.49%
patent report global market

Large Molecule Injectable Drugs Market to grow by USD 191.45 billion from 2022-2027 | North America to account for 45% of market growth - Technavio
Published: 2023-09-18 (Crawled : 09:00) - prnewswire.com
GLAXF | $20.2 510

| 9.19% | O: 2.7% H: 0.0% C: -5.11%
AZNCF | $135.94 770

| -1.69% | O: -2.01% H: 1.73% C: -2.99%
NVSEF | $93.6375 82K

| 9.62% | O: -0.05% H: 0.0% C: -1.31%
NVS | $93.07 -1.42% 280K

| -8.01% | O: 0.06% H: 0.09% C: -0.6%
MDT | $79.22 -1.26% 1.4M

| -0.95% | O: 0.59% H: 1.69% C: 0.67%
GSK | $39.9 -1.48% 650K

| 8.2% | O: 0.72% H: 0.13% C: -0.93%
BAX | $39.685 -0.89% 380K

| 2.46% | O: -0.13% H: 0.28% C: -0.77%
ABBV | $163.08 0.87% 500K

| 5.91% | O: 0.33% H: 0.0% C: 0.0%
SNY | $45.99 0.13% 70K

| -14.78% | O: -1.29% H: 0.0% C: 0.0%
BIIB | $195.95 -0.43% 70K

| -22.76% | O: 0.06% H: 0.44% C: -0.64%
AZN | $68.34 -0.57% 750K

| 0.67% | O: -0.76% H: 0.16% C: -1.65%
AMGN | $265.07 -0.17% 280K

| 1.84% | O: 1.02% H: 0.7% C: -0.09%
america growth market

Anti-rheumatic Market to Grow Exponentially by 2029- Brandessence Market Research
Published: 2023-09-01 (Crawled : 14:30) - prnewswire.com
AZNCF | $135.94 770

| 1.42% | O: 1.46% H: 0.0% C: 0.0%
ALPMY | $9.2715 500K

| -38.76% | O: -0.07% H: 3.3% C: 0.26%
ABBV | $163.08 0.87% 500K

| 8.91% | O: -0.35% H: 0.0% C: 0.0%
CPIX | $1.55 12K

| -6.06% | O: 0.61% H: 0.0% C: 0.0%
BIIB | $195.95 -0.43% 70K

| -26.39% | O: 0.62% H: 0.26% C: -0.68%
AZN | $68.34 -0.57% 750K

| 1.34% | O: 0.86% H: 0.16% C: -0.38%
AMGN | $265.07 -0.17% 280K

| 3.58% | O: 0.91% H: 0.14% C: -0.76%
research market

Acute Ischemic Stroke Therapeutics Market to grow by USD 1,524.49 million from 2022 to 2027|Rising prevalence of disease boosts the market - Technavio
Published: 2023-07-10 (Crawled : 19:00) - prnewswire.com
MDT | $79.22 -1.26% 1.4M

| -6.32% | O: -0.15% H: 1.17% C: 1.12%
SNY | $45.99 0.13% 70K

| -9.78% | O: -0.12% H: 0.0% C: 0.0%
BIIB | $195.95 -0.43% 70K

| -30.11% | O: -0.56% H: 0.19% C: -0.06%
AZN | $68.34 -0.57% 750K

| 5.43% | O: -0.28% H: 0.25% C: -0.23%
AMGN | $265.07 -0.17% 280K

| 18.15% | O: -0.4% H: 0.78% C: 0.01%
disease stroke therapeutics market

Protein Therapeutics Market size to grow by USD 153.56 billion, the availability of favorable reimbursement policies to drive the market growth - Technavio
Published: 2023-04-28 (Crawled : 01:00) - prnewswire.com
SNYNF | $92.966 630

| -16.51% | O: -1.21% H: 0.12% C: -2.76%
AZNCF | $135.94 770

| -6.89% | O: -0.41% H: 0.79% C: 0.79%
NVS | $93.07 -1.42% 280K

| -8.03% | O: -0.79% H: 0.89% C: 0.72%
ABBV | $163.08 0.87% 500K

| 8.6% | O: -0.6% H: 2.31% C: 2.13%
SNY | $45.99 0.13% 70K

| -15.9% | O: -2.09% H: 0.0% C: 0.0%
BIIB | $195.95 -0.43% 70K

| -33.0% | O: 0.06% H: 3.94% C: 3.51%
AZN | $68.34 -0.57% 750K

| -6.84% | O: -1.03% H: 1.02% C: 0.28%
AMGN | $265.07 -0.17% 280K

| 10.47% | O: -1.46% H: 1.39% C: 1.23%
favorable protein therapeutics growth market

Non-hodgkin lymphoma therapeutics market size to increase by USD 5,427.51 million between 2022 and 2027; Growing awareness about cancer as a key trend - Technavio
Published: 2023-03-24 (Crawled : 19:00) - prnewswire.com
NVS | $93.07 -1.42% 280K

| Email alert Add to watchlist
AZNCF | $135.94 770

| Email alert Add to watchlist
BIIB | $195.95 -0.43% 70K

| Email alert Add to watchlist
BAX | $39.685 -0.89% 380K

| Email alert Add to watchlist
GSK | $39.9 -1.48% 650K

| Email alert Add to watchlist
GLAXF | $20.2 510

| Email alert Add to watchlist
TEVJF | $12.37 -24.22% 380

| Email alert Add to watchlist
NVSEF | $93.6375 82K

| Email alert Add to watchlist
SGEN | $228.74 0.1% 20M

| Email alert Add to watchlist
AZN | $68.34 -0.57% 750K

| Email alert Add to watchlist
cancer growing therapeutics market

Global API and Pharmaceutical Excipients Market Report 2022-2029 Featuring Catalent, Divis Labs, Euroapi Lonza, Pfizer, Samsung Biologics, Teva, Thermo Fisher Scientific, Wuxi Apptec, & Wuxi Biologics
Published: 2023-03-06 (Crawled : 20:00) - prnewswire.com
CMXHF | $180.75 33

| -7.93% | O: -0.86% H: 0.33% C: 0.33%
CSLLY | $89.5 44K

| -9.64% | O: -0.02% H: 0.54% C: -1.7%
AZNCF | $135.94 770

| 4.41% | O: -2.57% H: 1.62% C: 1.62%
TMO | $554.06 -0.68% 110K

| -0.12% | O: 0.41% H: 0.39% C: -2.14%
TEVA | $13.16 -0.53% 420K

| 33.5% | O: -1.21% H: 0.43% C: -3.58%
TAK | $13.275 0.72% 150K

| -15.73% | O: 0.83% H: 0.06% C: -1.2%
PRGO A | $29.885 -0.81% 54K

| -18.48% | O: 0.76% H: 1.91% C: 1.26%
GSK | $39.9 -1.48% 650K

| 17.56% | O: 0.32% H: 0.17% C: -1.53%
LLY | $749.58 -0.16% 450K

| 135.38% | O: 0.01% H: 0.42% C: -2.62%
CTLT | $56.08 110K

| -21.39% | O: 0.11% H: 0.53% C: -5.05%
BMY | $48.325 -0.38% 1M

| -29.59% | O: 0.41% H: 0.04% C: -1.71%
ALB | $117.875 -2.18% 510K

Process Industries

| -53.09% | O: -0.95% H: 1.02% C: -2.19%
ABBV | $163.08 0.87% 500K

| 4.12% | O: 0.19% H: 0.06% C: -1.7%
SNY | $45.99 0.13% 70K

| -1.8% | O: 0.65% H: 0.0% C: 0.0%
GILD | $67.36 -0.58% 700K

| -16.47% | O: 0.23% H: 0.0% C: -1.25%
BIIB | $195.95 -0.43% 70K

| -27.18% | O: 0.28% H: 0.0% C: -2.26%
AZN | $68.34 -0.57% 750K

| 6.46% | O: 0.9% H: 0.28% C: -1.3%
global report market

Worldwide Monoclonal Antibodies Industry to 2033 - Rising mAb Therapy Applications for Targeted Therapies Drives Growth
Published: 2023-01-18 (Crawled : 18:00) - prnewswire.com
GLAXF | $20.2 510

| 13.48% | O: 1.12% H: 0.0% C: -1.68%
SNYNF | $92.966 630

| -6.82% | O: -2.5% H: 0.0% C: 0.0%
AZNCF | $135.94 770

| -5.35% | O: -1.16% H: 1.62% C: -0.54%
NVSEF | $93.6375 82K

| 22.87% | O: 0.05% H: 0.0% C: 0.0%
VTRS | $11.195 -1.1% 470K

| -4.39% | O: -0.17% H: 0.25% C: -2.96%
TMO | $554.06 -0.68% 110K

| -5.1% | O: 0.56% H: 0.97% C: -1.87%
NVO | $123.5 -0.32% 1M

| -10.85% | O: 0.57% H: 0.84% C: -0.01%
NVS | $93.07 -1.42% 280K

| 2.2% | O: 0.93% H: 0.01% C: -1.16%
JNJ | $144.84 -1.86% 3M

| -14.37% | O: -0.41% H: 0.2% C: -1.1%
GSK | $39.9 -1.48% 650K

| 13.89% | O: -0.03% H: 0.17% C: -1.01%
LLY | $749.58 -0.16% 450K

| 109.86% | O: -0.4% H: 0.75% C: -1.21%
ABT | $108.85 -0.04% 860K

| -3.97% | O: -0.16% H: 0.33% C: -1.5%
SNY | $45.99 0.13% 70K

| -5.94% | O: -0.14% H: 0.0% C: 0.0%
BIIB | $195.95 -0.43% 70K

| -32.04% | O: 0.34% H: 0.46% C: -2.45%
AZN | $68.34 -0.57% 750K

| -2.84% | O: 1.36% H: 0.33% C: -1.13%
AMGN | $265.07 -0.17% 280K

| -1.45% | O: 0.0% H: 0.41% C: -1.87%
therapy growth

Acute Ischemic Stroke Therapeutics Market: Growth Opportunities led by Athersys Inc. and Bayer AG - Technavio
Published: 2022-11-28 (Crawled : 21:00) - prnewswire.com
SNYNF | $92.966 630

| 3.54% | O: 0.36% H: 0.16% C: 0.16%
AZNCF | $135.94 770

| 1.52% | O: -1.93% H: 0.0% C: 0.0%
MDT | $79.22 -1.26% 1.4M

| 6.38% | O: 0.35% H: 0.99% C: 0.1%
JNJ | $144.84 -1.86% 3M

| -16.77% | O: -0.18% H: 0.14% C: -0.52%
SNY | $45.99 0.13% 70K

| 2.43% | O: 0.01% H: 0.0% C: 0.0%
BIIB | $195.95 -0.43% 70K

| -32.58% | O: -0.27% H: 0.99% C: 0.11%
AZN | $68.34 -0.57% 750K

| 3.81% | O: 0.21% H: 0.16% C: -0.41%
AMGN | $265.07 -0.17% 280K

| -6.05% | O: 0.27% H: 0.0% C: -0.49%
stroke therapeutics growth

Neuropathy Pain Treatment Market Size to Grow by USD 3.81 Bn, Growing Focus on Emerging Economies to be a Key Trend - Technavio
Published: 2022-10-04 (Crawled : 11:00) - prnewswire.com
ENDPQ | $0.0018 420K

| -98.03% | O: -1.75% H: 17.22% C: 10.78%
ALPMF | $9.48 1.7K

| -26.85% | O: 5.79% H: 0.0% C: 0.0%
SNYNF | $92.966 630

| 22.07% | O: 8.97% H: 0.0% C: 0.0%
AZNCF | $135.94 770

| 22.19% | O: 0.45% H: 2.01% C: 1.12%
ALPMY | $9.2715 500K

| -30.76% | O: 1.34% H: 1.11% C: 1.11%
NVS | $93.07 -1.42% 280K

| 23.14% | O: 1.37% H: 1.04% C: 0.66%
GSK | $39.9 -1.48% 650K

| 33.88% | O: 1.59% H: 0.93% C: -0.07%
BAX | $39.685 -0.89% 380K

| -28.01% | O: 0.99% H: 2.56% C: 2.28%
ABT | $108.85 -0.04% 860K

| 9.42% | O: 1.23% H: 2.45% C: 2.32%
SNY | $45.99 0.13% 70K

| 21.21% | O: 2.72% H: 0.0% C: 0.0%
BIIB | $195.95 -0.43% 70K

| -25.54% | O: 0.64% H: 1.45% C: 0.55%
AZN | $68.34 -0.57% 750K

| 23.73% | O: 1.42% H: 1.38% C: 1.24%
treatment growing market

T-cell lymphoma Market 2026, Growing Geriatric Population to Boost Growth - Technavio
Published: 2022-09-26 (Crawled : 06:00) - prnewswire.com
SNYNF | $92.966 630

| 26.73% | O: 5.77% H: 0.0% C: -2.27%
AZNCF | $135.94 770

| 25.46% | O: -1.15% H: 0.0% C: -2.43%
NVS | $93.07 -1.42% 280K

| 24.21% | O: -2.04% H: 0.82% C: 0.2%
BAX | $39.685 -0.89% 380K

| -27.74% | O: -0.45% H: 0.6% C: -0.45%
ABBV | $163.08 0.87% 500K

| 13.01% | O: -0.69% H: 0.51% C: -0.61%
SNY | $45.99 0.13% 70K

| 22.12% | O: -2.29% H: 0.35% C: -0.67%
BIIB | $195.95 -0.43% 70K

| -0.5% | O: -0.17% H: 1.2% C: -0.86%
AUTL | $4.91 0.2% 58K

| 140.2% | O: 2.94% H: 1.43% C: -0.48%
AZN | $68.34 -0.57% 750K

| 25.93% | O: -1.52% H: 0.48% C: -1.36%
growing t-cell growth market

Global Central Nervous System Therapeutics Market to Grow at Healthy CAGR Due to Rising Disorder Prevalence & Technical Advancements
Published: 2022-09-19 (Crawled : 21:00) - prnewswire.com
GLAXF | $20.2 510

| 30.32% | O: -6.97% H: 7.7% C: -0.76%
AZNCF | $135.94 770

| 22.51% | O: -0.34% H: 6.64% C: -0.06%
NVSEF | $93.6375 82K

| 47.56% | O: 1.96% H: 0.0% C: 0.0%
NVS | $93.07 -1.42% 280K

| 16.95% | O: -0.82% H: 0.07% C: -0.61%
JNJ | $144.84 -1.86% 3M

| -10.96% | O: -0.33% H: 0.0% C: 0.0%
GSK | $39.9 -1.48% 650K

| 31.58% | O: -0.71% H: 0.2% C: -0.23%
LLY | $749.58 -0.16% 450K

| 146.08% | O: -0.42% H: 0.0% C: -0.69%
SNY | $45.99 0.13% 70K

| 16.23% | O: -1.18% H: 0.0% C: 0.0%
BIIB | $195.95 -0.43% 70K

| -5.95% | O: -0.71% H: 0.08% C: -1.72%
AZN | $68.34 -0.57% 750K

| 18.52% | O: -1.16% H: 0.56% C: 0.14%
AMGN | $265.07 -0.17% 280K

| 15.06% | O: -0.98% H: 0.65% C: -0.35%
global system therapeutics market

Cancer Biologics Market to record USD 34.97 Bn growth, Evolving Opportunities with Amgen Inc. and AstraZeneca Plc
Published: 2022-09-19 (Crawled : 07:00) - prnewswire.com
GLAXF | $20.2 510

| 31.25% | O: -8.32% H: 12.85% C: 9.85%
AZNCF | $135.94 770

| 20.3% | O: 1.63% H: 0.14% C: -3.38%
NVS | $93.07 -1.42% 280K

| 17.06% | O: -0.52% H: 0.69% C: 0.62%
GSK | $39.9 -1.48% 650K

| 31.37% | O: -0.55% H: 0.64% C: 0.39%
JAZZ | $110.57 -0.31% 72K

| -24.8% | O: -0.54% H: 1.18% C: 0.94%
BIIB | $195.95 -0.43% 70K

| -5.5% | O: -0.66% H: 1.6% C: 1.15%
AZN | $68.34 -0.57% 750K

| 18.4% | O: -0.14% H: 0.09% C: 0.03%
AMGN | $265.07 -0.17% 280K

| 14.87% | O: -0.22% H: 0.1% C: 0.05%
cancer market

World Neurological Diseases Treatment Market Analysis Report 2022: Treatment for Alzheimer's Top the Market Revenues - Forecast to 2030
Published: 2022-09-16 (Crawled : 19:00) - prnewswire.com
TEVJF | $12.37 -24.22% 380

| Email alert Add to watchlist
GSK | $39.9 -1.48% 650K

| Email alert Add to watchlist
AZN | $68.34 -0.57% 750K

| Email alert Add to watchlist
AZNCF | $135.94 770

| Email alert Add to watchlist
NVSEF | $93.6375 82K

| Email alert Add to watchlist
ITCI | $81.085 25.21% 3.1M

| Email alert Add to watchlist
JNJ | $144.84 -1.86% 3M

| Email alert Add to watchlist
BIIB | $195.95 -0.43% 70K

| Email alert Add to watchlist
ABBV | $163.08 0.87% 500K

| Email alert Add to watchlist
GLAXF | $20.2 510

| Email alert Add to watchlist
NVS | $93.07 -1.42% 280K

| Email alert Add to watchlist
treatment report alzheimer's neurological market

Idiopathic Pulmonary Fibrosis Market Size to hit USD 5326.8 Million in 2028 | Growing at 7.1 % CAGR, Says Brandessence Market Research
Published: 2022-06-03 (Crawled : 12:00) - prnewswire.com
AZNCF | $135.94 770

| 5.61% | O: -0.4% H: 4.05% C: -1.35%
BMY | $48.325 -0.38% 1M

| -35.72% | O: -1.4% H: 0.0% C: 0.0%
GLPG | $29.51 -0.97% 63K

| -46.25% | O: 0.29% H: 2.68% C: 2.39%
FGEN | $1.285 -1.91% 93K

| -86.28% | O: 1.57% H: 2.99% C: 2.99%
BIIB | $195.95 -0.43% 70K

| 0.5% | O: 1.16% H: 3.3% C: 1.27%
AZN | $68.34 -0.57% 750K

| 3.37% | O: -0.56% H: 0.82% C: -0.64%
fibrosis research growing market

Idiopathic Pulmonary Fibrosis Market to Reach $6.16 Bn, Globally, by 2030 at 7.0% CAGR: Allied Market Research
Published: 2022-02-07 (Crawled : 13:30) - prnewswire.com
AZNCF | $135.94 770

| 22.99% | O: 2.69% H: 0.5% C: -1.76%
BMY | $48.325 -0.38% 1M

| -23.06% | O: 3.7% H: 1.64% C: 1.24%
GLPG | $29.51 -0.97% 63K

| -54.19% | O: 2.54% H: 1.58% C: 0.1%
FGEN | $1.285 -1.91% 93K

| -91.08% | O: -1.09% H: 9.3% C: 8.82%
BIIB | $195.95 -0.43% 70K

| -8.57% | O: 2.54% H: 0.0% C: 0.0%
AZN | $68.34 -0.57% 750K

| 22.14% | O: -0.14% H: 1.01% C: 0.87%
fibrosis research

Gainers vs Losers

48%

52%

Top 10 Gainers

TPET | $0.4801 107.75% 16M

JAGX | $0.23 93.6% 310M

WISA 4 | $3.17 81.14% 36M

Electronic Technology

PALI | $6.57 57.93% 19M

SPCB | $0.4278 55.0% 17M

Electronic Technology

BTTR | $7.61 49.22% 1.8M

PRSO | $1.79 40.95% 25M

DYNT | $0.5203 40.47% 17M

MCBC | $13.755 38.52% 620K

Finance

SNGX | $0.5155 33.52% 3.9M